Trump Signs Executive Order Doubling AI Funding for Pediatric Cancer Research

President Trump and Pediatric Cancer

Formal Complaint about the 2025 EU4Health Operating Grant Procedure to the European Ombudswoman - AECL

Formal Complaint about the 2025 EU4Health Operating Grant Procedure to the European Ombudswoman - AECL

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Julio Aguirre-Ghiso: Metastasis and the Real Causes of Cancer Mortality

Julio Aguirre-Ghiso: Metastasis and the Real Causes of Cancer Mortality

Ophira Ginsburg: Perilous Time for the Rights of Women and Girls

Ophira Ginsburg

New Paper Alert: Managing Key Adverse Events of Sacituzumab Govitecan in Breast Cancer

Sacituzumab Govitecan

Uta Dirksen: Our New Paper on Novel and Deeply Characterized Ewing Sarcoma Cell Lines

Uta Dirksen

Aleix Prat: DNADX ctDNA Testing in Patients Treated with Sacituzumab Govitecan for Metastatic Breast Cancer

Aleix Prat

OncoCalendar

Loading Events

« All Events

  • This event has passed.

Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM)

Mar 25 • 12:00 AM - Mar 29 • 12:00 AM
Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM)

Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM) will be held from March 25, 2025 – May 29, 2026. It’s a hybrid event and the offline venues will change either.

The Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM) is a joint collaboration between the European School of Oncology (ESO) and the University of Fribourg, Switzerland.  The programme will focus on the improvement on both the clinical and the scientific aspects of improving quality in the management of patients with lung cancer and other thoracic malignancies.  Upon successful completion of the programme, participants will obtain an academic certificate assigning 14 ECTS credits, equalling a work load of 420 hours and a diploma supplement by the University of Fribourg.